General Archive

Home » News releases » Page 28
  • News releases

    DiscoveRX, GSK & MRCT collaborate to de-orphanise GPCRs

    DiscoveRX, GSK & MRCT collaboration to de-orphanise GPCRs mentioned in an article about universities driving new technology businesses in the…

    Read more

  • News releases

    Bicycle Therapeutics is new MRC spinout

    The spin out is a new biotechnology company developing a novel technology platform for the creation of a new generation…

    Read more

  • News releases

    DiscoveRX GSK and MRCT collaborate to deorphanise GPCRs

    The three way alliance aims to seek out natural substances that bind to G-protein-coupled receptors (GPCRs). Through the identification of…

    Read more

  • News releases

    Centre for Therapeutics Discovery

    A major centre to fast-track the discovery and development of novel drugs will be created by the Medical Research Council…

    Read more

  • News releases

    Heptares secures funding

    Heptares has raised GBP21 million (US$30 million) of equity finance in a successful Series A private round from three blue-chip…

    Read more

  • News releases

    UK Drug Discovery Consortium symposium

    ‘Imperial College London‘, ‘Cancer Research UK Centre for Cancer Therapeutics at The Institute of Cancer Research’, ‘ Drug Discovery Unit,…

    Read more

  • News releases

    MRCT licence rights to develop potential novel immunotherapy

    Centocor Ortho Biotech have signed agreements for the development of a novel immunotherapy targeting respiratory disease. The potential therapy was…

    Read more

  • News releases

    MRCT and Biolex Therapeutics complete successful collaborations

    MRCT has successfully completed the humanization of a novel antibody targeting CD20, indicated in Non-Hodgkin’s lymphoma and rheumatoid arthritis. Biolex…

    Read more

  • News releases

    Intellect Neurosciences and MRCT reach antibody milestone

    The milestone is an important stage in the collaborative efforts to humanize Intellect’s lead antibody IN-N01 necessary for creating a…

    Read more

  • News releases

    Development Gap Fund extended

    The MRC has approved a further £6 million of funding for a continuation of the MRCT Development Gap Fund (DGF).…

    Read more

  • News releases

    New Tysabri data released

    Biogen Idec and Elan Corporation, plc have announced new data on the global utilization, safety and overall patient exposure of…

    Read more

  • News releases

    How malaria parasites escape blood cells

    a collaboration between teams at the MRC’s National Institute for Medical Research and MRCT’s Drug Discovery Group has produced a…

    Read more